Usefulness of transient elastography (Fibroscan®) in the assessment of fibrosis in patients with chronic liver disease;UTilidad de la Elastografía de Transición (Fibroscan®) en la Evaluación de la Fibrosis Hepática en Pacientes con Hepatopatía Crónica

Medicina (Argentina)

Volumn 72, Issue 1, 2012, Pages 10-14

  Álvarez, Daniel ^a   Anders, María ^a   Mella, José ^a   Amante, Marcelo ^a   Orozco, Federico ^a   Mastai, Ricardo ^a  

^a HOSPITAL ALEMÁN   (Argentina)

Author keywords

Elastography; Fibroscan ; Liver cirrhosis; Non invasive

Indexed keywords

ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ASSESSMENT; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE SEVERITY; ECHOGRAPHY; ELASTOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MEDICAL SPECIALIST; PATIENT SAFETY; BIOPSY; CHRONIC DISEASE; CROSS-SECTIONAL STUDY; EVALUATION; FEMALE; FIBROSIS; LIVER; MALE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; STANDARD;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; BIOPSY; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; ELASTICITY IMAGING TECHNIQUES; FEMALE; FIBROSIS; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED;

EID: 84862232519     PISSN: 00257680     EISSN: 16699106     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Perrillo RP. The role of liver biopsy in hepatitis C. Hepatology 1997; 26: 57S-61S.
2. Sasdeh S, Cammell G, Carey WD, et al. The role of liver biopsy in chronic hepatitis C. Hepatology 2001; 33: 196-200.
3. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-57.
4. Colloredo G, Guido M, Sonzogni A, et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003; 39: 239-44.
5. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48: 835-47.
6. Fraquelli M, Rigamonti C, Casazza G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56: 968-73.
7. Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: A new non invasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-13.
8. Foucher J, Castera L, Bernard PH, et al. Prevalence and fac-factors associated with failure of liver stiffness measurement using Fibroscan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol.2006; 18: 411-2.
9. Bedossa P, Poynard T. The Metavir Cooperative Study Group. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24: 289-93,
10. Zweig M H, Campbell G. Receiver-Operating Characteristic (ROC) Plots: fundamental evaluation tool in Clinical Medicine. Clin Chem 1993; 39: 561-77.
11. García G, Keeffe EB. Liver biopsy in chronic hepatitis C: routine or selective. Am J Gastroenterol 2001; 96: 3053-5.
12. Wong JB, Bennett WG, Koff RS, et al. Pretreatment evaluation of chronic hepatitis C. Risk benefits and costs. JAMA 1998; 280: 2088-93.
13. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Eng J Med 2001; 344: 495-500.
14. Carrion JA. Alternativas a la biopsia hepática en pacientes con infección crónica por el virus de la hepatitis C. Gastroenterol Hepatol 2008; 31: 7-13.
15. Copechot C, El Naggar A, Poujol-Robert A, et al. Assessment of biliary fibrosis by trasientelastography in patients with PBC and PSC. Hepatology 2006; 43: 1118-24.